Swiss Roche invests $888m to expand biologic medicines facilities

14 October 2013 08:04  [Source: ICIS news]

SINGAPORE (ICIS)--Roche is planning to invest Swiss francs (Swfr) 800m ($888m) to expand its production capabilities for biologic medicines over the next five years, the Swiss pharmaceuticals firm said on Monday.

The investment will involve sites at Penzberg in Germany, Basel in Switzerland as well as Vacaville and Oceanside in the US, it said in a statement.

The facility expansions will create about 500 new jobs, it added.

($1 = Swfr0.90)


By: Nurluqman Suratman



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly